Dow Down 0.08% Nasdaq Down 0.35%

Arbutus Biopharma Corporation (ABUS)

-NasdaqCM
3.00 Up 0.10(3.45%) 4:00PM EST
Prev Close:2.90
Open:2.85
Bid:1.25 x 2000
Ask:3.85 x 3000
1y Target Est:14.25
Beta:0.967568
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:2.72 - 3.04
52wk Range:2.72 - 22.77
Volume:315,476
Avg Vol (3m):299,303
Market Cap:163.71M
P/E (ttm):N/A
EPS (ttm):-1.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABUS

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.41
Quarterly EPS Est (Dec-15) :-0.41
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arbutus Biopharma Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics, and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback